Category: Business and Investments
Long-term immune response for Vical's TransVax™ vaccine in Phase 2 trial
Vical Incorporated (Nasdaq:VICL) announced that TransVax™ cytomegalovirus vaccine continued to demonstrate an overall increase in …
Inovio reports clinical trial progress of cervical cancer vaccine
Inovio Biomedical Corporation (NYSE Amex: INO) announced safety and immunogenicity data from its therapeutic cervical …
Immunovaccine begins trading as “IMV”
Immunovaccine Inc. (TSX-V:IMV) will begin trading on the TSX-Venture Exchange as a Tier 1 issuer …
Oncolytics enters into agreement with FDA for Phase 3 trial of REOLYSIN®
Oncolytics Biotech Inc. (“Oncolytics”) (TSX:ONC, NASDAQ:ONCY) has reached an agreement with the FDA under the …
WILEX receives approval for Phase I trial
WILEX AG (ISIN DE0006614720 / Frankfurt Stock Exchange / Prime Standard) announced that the German …
Medicago begins human testing of flu vaccine
Medicago Inc. (TSX-V: MDG) announced a Phase I trial for its H5N1 Avian Influenza vaccine. …
Provectus starts Phase 1 trial for liver cancer treatment
Provectus Pharmaceuticals, Inc. (OTCBB: PVCT) has initiated a Phase 1 study of PV-10 for liver …
XOMA to initiate Phase 2 program for Type 2 Diabetes and Cardiovascular Disease
XOMA Ltd. (Nasdaq:XOMA) announced plans for the Phase 2 clinical development of its anti-inflammatory drug …
U.S. Navy to fund Vical's H1N1 vaccine
The U.S. Navy has awarded a contract for $1.25 million to Vical Incorporated (Nasdaq:VICL) for …
Hana Biosciences’ clinical trial agreement with the National Cancer Institute
Hana Biosciences (OTCBB:HNAB) announced a Clinical Trial Agreement with the Center for Cancer Research (CCR) …